BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11206189)

  • 1. The biopharmaceutical aspects of nasal mucoadhesive drug delivery.
    Ugwoke MI; Verbeke N; Kinget R
    J Pharm Pharmacol; 2001 Jan; 53(1):3-21. PubMed ID: 11206189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal clearance in health and disease.
    Illum L
    J Aerosol Med; 2006; 19(1):92-9. PubMed ID: 16551220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
    Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
    Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal route and drug delivery systems.
    Türker S; Onur E; Ozer Y
    Pharm World Sci; 2004 Jun; 26(3):137-42. PubMed ID: 15230360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.
    Ugwoke MI; Agu RU; Verbeke N; Kinget R
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1640-65. PubMed ID: 16182408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal drug delivery: how, why and what for?
    Pires A; Fortuna A; Alves G; Falcão A
    J Pharm Pharm Sci; 2009; 12(3):288-311. PubMed ID: 20067706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in nasal drug absorption: how far have we come?
    Agu RU
    Ther Deliv; 2016 Jul; 7(7):495-510. PubMed ID: 27403632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends in drug delivery systems: intranasal drug delivery.
    Agarwal V; Mishra B
    Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal administration of liquid crystal precursor mucoadhesive vehicle as an alternative antiretroviral therapy.
    Carvalho FC; Campos ML; Peccinini RG; Gremião MP
    Eur J Pharm Biopharm; 2013 May; 84(1):219-27. PubMed ID: 23207328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
    Scherließ R
    Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the nasal mucociliary system on intranasal drug administration.
    Wang J; Bu G
    Chin Med J (Engl); 2000 Jul; 113(7):647-9. PubMed ID: 11776039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of nanoparticulate drug delivery systems by intranasal administration.
    Ali J; Ali M; Baboota S; Sahani JK; Ramassamy C; Dao L; Bhavna
    Curr Pharm Des; 2010 May; 16(14):1644-53. PubMed ID: 20210751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal delivery of levonorgestrel for contraception: an experimental study in rats.
    Shahiwala A; Misra A
    Fertil Steril; 2004 Mar; 81 Suppl 1():893-8. PubMed ID: 15019826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal drug delivery--possibilities, problems and solutions.
    Illum L
    J Control Release; 2003 Feb; 87(1-3):187-98. PubMed ID: 12618035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nasal mucociliary clearance: relevance to nasal drug delivery.
    Schipper NG; Verhoef JC; Merkus FW
    Pharm Res; 1991 Jul; 8(7):807-14. PubMed ID: 1924131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.